Novartis wins FDA approval for two blood pressure drugs

08/4/2008 | Reuters · Bloomberg

Novartis obtained FDA clearance for Diovan HCT and Exforge, two single-pill treatments for high blood pressure. The approval allows the use of the combination drugs as an initial treatment for hypertension patients who may need multiple regimens, the company said.

View Full Article in:

Reuters · Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI